Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Noel G. Faux"'
Autor:
Martin Saint-Jalmes, Victor Fedyashov, Daniel Beck, Timothy Baldwin, Noel G. Faux, Pierrick Bourgeat, Jurgen Fripp, Colin L. Masters, Benjamin Goudey
Publikováno v:
NeuroImage, Vol 278, Iss , Pp 120279- (2023)
The recent biological redefinition of Alzheimer’s Disease (AD) has spurred the development of statistical models that relate changes in biomarkers with neurodegeneration and worsening condition linked to AD. The ability to measure such changes may
Externí odkaz:
https://doaj.org/article/d10a253954e547b699e2b2e6b86c3995
Autor:
Pasi K. Korhonen, Babak Shaban, Noel G. Faux, Liina Kinkar, Bill C. H. Chang, Daxi Wang, Bicheng Yang, Neil D. Young, Robin B. Gasser
Publikováno v:
Molecular ecology resources. 22(5)
The revolution in genomics has enabled large-scale population genetic investigations of a wide range of organisms, but there has been a relatively limited focus on improving analytical pipelines. To efficiently analyse large data sets, highly integra
Autor:
Noel G Faux, Stefanie Bird, Aleks Michalewicz, Julie A Pasco, Myrla P Reis Sales, Daniel Russo‐Batterham, Sara Vogrin, Lana j Williams, Gustavo Duque, Cassandra Szoeke
Publikováno v:
Alzheimer's & Dementia. 17
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Noel G. Faux, Samantha C. Burnham, James D. Doecke, Ashley I. Bush, Greg Savage, David Baker, Paul Maruff, Colin L. Masters, Stephanie R. Rainey-Smith, Ralph N. Martins, S. Lance Macaulay, David Ames, Simon M. Laws, Victor L. Villemagne, Christopher C. Rowe, William Wilson
Publikováno v:
Neurology. 87:1093-1101
Objective:We assessed a blood-based signature, which previously demonstrated high accuracy at stratifying individuals with high or low neocortical β-amyloid burden (NAB), to determine whether it could also identify individuals at risk of progression
Autor:
Irene Volitakis, Noel G. Faux, Blaine R. Roberts, Ashley I. Bush, Dominic J. Hare, Ralph N. Martins
Publikováno v:
Metallomics. 8:628-632
We examined serum and erythrocyte lead and manganese levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL), which contains over 1000 registrants including over 200 cases of Alzheimer's disease (AD) and 100 mildly
Publikováno v:
Alzheimer's & Dementia. 14
Publikováno v:
Alzheimer's & Dementia. 14
Publikováno v:
mSphere, Vol 6, Iss 3 (2021)
mSphere
mSphere
Background:The evolution and spread of antimicrobial resistance is a major global public health threat. In some cases the evolution of resistance to one antimicrobial seemingly results in enhanced sensitivity to another (known as ‘collateral sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::717713c19353b21f2d6c105c234d2c00
Autor:
Alan Rembach, Christopher Fowler, Keyla Perez, Brett Trounson, Rebecca L. Rumble, Victor L. Villemagne, Noel G. Faux, Kevin J. Barnham, Kelly K. Pertile, Andrew D Watt, Paul O'Donnell, Colin L. Masters, Ching-Seng Ang
Publikováno v:
Journal of Alzheimer's Disease. 44:1131-1143
Biomarkers enabling the preclinical identification of Alzheimer's disease (AD) remain one of the major unmet challenges in the field. The blood cellular fractions offer a viable alternative to current cerebrospinal fluid and neuroimaging modalities.